0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pancreatic Cancer Diagnostic Devices Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-29W876
Home | Market Reports | Health| Health Conditions| Cancer
Global Pancreatic Cancer Diagnostic Devices Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pancreatic Cancer Diagnostic Devices Market Insights, Forecast to 2030

Code: QYRE-Auto-29W876
Report
December 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pancreatic Cancer Diagnostic Devices Market Size

The global Pancreatic Cancer Diagnostic Devices market is projected to grow from US$ 5871.7 million in 2024 to US$ 6769.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.4% during the forecast period.

Pancreatic Cancer Diagnostic Devices Market

Pancreatic Cancer Diagnostic Devices Market

Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of pancreatic cancer are known. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and the term "pancreatic cancer" is sometimes used to refer only to that type. These adenocarcinomas start within the part of the pancreas that makes digestive enzymes. Several other types of cancer, which collectively represent the majority of the no adenocarcinomas, can also arise from these cells. About 1-2% of cases of pancreatic cancer are neuroendocrine tumors, which arise from the hormone-producing cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma.
Market Analysis and Insights: Global Pancreatic Cancer Diagnostic Devices Market
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Pancreatic Cancer Diagnostic Devices market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pancreatic Cancer Diagnostic Devices, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pancreatic Cancer Diagnostic Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pancreatic Cancer Diagnostic Devices revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pancreatic Cancer Diagnostic Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pancreatic Cancer Diagnostic Devices revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pancreatic Cancer Diagnostic Devices Market Report

Report Metric Details
Report Name Pancreatic Cancer Diagnostic Devices Market
Accounted market size in 2024 US$ 5871.7 in million
Forecasted market size in 2030 US$ 6769.6 million
CAGR 2.4
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, GE Healthcare, Siemens, BD, Philips Healthcare, Hitachi Medical, Danaher, Abbott, Canon Medical Systems, Myriad Genetics, Qiagen, Asuragen, BioMarker Strategies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Pancreatic Cancer Diagnostic Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pancreatic Cancer Diagnostic Devices companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pancreatic Cancer Diagnostic Devices revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Pancreatic Cancer Diagnostic Devices Market growing?

Ans: The Pancreatic Cancer Diagnostic Devices Market witnessing a CAGR of 2.4 during the forecast period 2025-2030.

What is the Pancreatic Cancer Diagnostic Devices Market size in 2030?

Ans: The Pancreatic Cancer Diagnostic Devices Market size in 2030 will be US$ 6769.6 million.

Who are the main players in the Pancreatic Cancer Diagnostic Devices Market report?

Ans: The main players in the Pancreatic Cancer Diagnostic Devices Market are Roche, GE Healthcare, Siemens, BD, Philips Healthcare, Hitachi Medical, Danaher, Abbott, Canon Medical Systems, Myriad Genetics, Qiagen, Asuragen, BioMarker Strategies

What are the Application segmentation covered in the Pancreatic Cancer Diagnostic Devices Market report?

Ans: The Applications covered in the Pancreatic Cancer Diagnostic Devices Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Pancreatic Cancer Diagnostic Devices Market report?

Ans: The Types covered in the Pancreatic Cancer Diagnostic Devices Market report are Imaging, Tumor Biomarker, Biopsy, Others

Recommended Reports

Cancer Diagnostics Devices

Pancreatic & Related Therapy

Oncology Testing Equipment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Cancer Diagnostic Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Imaging
1.2.3 Tumor Biomarker
1.2.4 Biopsy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pancreatic Cancer Diagnostic Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Cancer Diagnostic Devices Market Perspective (2019-2030)
2.2 Global Pancreatic Cancer Diagnostic Devices Growth Trends by Region
2.2.1 Pancreatic Cancer Diagnostic Devices Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pancreatic Cancer Diagnostic Devices Historic Market Size by Region (2019-2024)
2.2.3 Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Region (2025-2030)
2.3 Pancreatic Cancer Diagnostic Devices Market Dynamics
2.3.1 Pancreatic Cancer Diagnostic Devices Industry Trends
2.3.2 Pancreatic Cancer Diagnostic Devices Market Drivers
2.3.3 Pancreatic Cancer Diagnostic Devices Market Challenges
2.3.4 Pancreatic Cancer Diagnostic Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pancreatic Cancer Diagnostic Devices by Players
3.1.1 Global Pancreatic Cancer Diagnostic Devices Revenue by Players (2019-2024)
3.1.2 Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Players (2019-2024)
3.2 Global Pancreatic Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pancreatic Cancer Diagnostic Devices, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pancreatic Cancer Diagnostic Devices Market Concentration Ratio
3.4.1 Global Pancreatic Cancer Diagnostic Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Diagnostic Devices Revenue in 2023
3.5 Global Key Players of Pancreatic Cancer Diagnostic Devices Head office and Area Served
3.6 Global Key Players of Pancreatic Cancer Diagnostic Devices, Product and Application
3.7 Global Key Players of Pancreatic Cancer Diagnostic Devices, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Cancer Diagnostic Devices Breakdown Data by Type
4.1 Global Pancreatic Cancer Diagnostic Devices Historic Market Size by Type (2019-2024)
4.2 Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Type (2025-2030)
5 Pancreatic Cancer Diagnostic Devices Breakdown Data by Application
5.1 Global Pancreatic Cancer Diagnostic Devices Historic Market Size by Application (2019-2024)
5.2 Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pancreatic Cancer Diagnostic Devices Market Size (2019-2030)
6.2 North America Pancreatic Cancer Diagnostic Devices Market Size by Type
6.2.1 North America Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024)
6.2.2 North America Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030)
6.2.3 North America Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
6.3 North America Pancreatic Cancer Diagnostic Devices Market Size by Application
6.3.1 North America Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024)
6.3.2 North America Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030)
6.3.3 North America Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
6.4 North America Pancreatic Cancer Diagnostic Devices Market Size by Country
6.4.1 North America Pancreatic Cancer Diagnostic Devices Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pancreatic Cancer Diagnostic Devices Market Size by Country (2019-2024)
6.4.3 North America Pancreatic Cancer Diagnostic Devices Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pancreatic Cancer Diagnostic Devices Market Size (2019-2030)
7.2 Europe Pancreatic Cancer Diagnostic Devices Market Size by Type
7.2.1 Europe Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024)
7.2.2 Europe Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030)
7.2.3 Europe Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
7.3 Europe Pancreatic Cancer Diagnostic Devices Market Size by Application
7.3.1 Europe Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024)
7.3.2 Europe Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030)
7.3.3 Europe Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
7.4 Europe Pancreatic Cancer Diagnostic Devices Market Size by Country
7.4.1 Europe Pancreatic Cancer Diagnostic Devices Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pancreatic Cancer Diagnostic Devices Market Size by Country (2019-2024)
7.4.3 Europe Pancreatic Cancer Diagnostic Devices Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pancreatic Cancer Diagnostic Devices Market Size (2019-2030)
8.2 China Pancreatic Cancer Diagnostic Devices Market Size by Type
8.2.1 China Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024)
8.2.2 China Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030)
8.2.3 China Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
8.3 China Pancreatic Cancer Diagnostic Devices Market Size by Application
8.3.1 China Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024)
8.3.2 China Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030)
8.3.3 China Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pancreatic Cancer Diagnostic Devices Market Size (2019-2030)
9.2 Asia Pancreatic Cancer Diagnostic Devices Market Size by Type
9.2.1 Asia Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024)
9.2.2 Asia Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030)
9.2.3 Asia Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
9.3 Asia Pancreatic Cancer Diagnostic Devices Market Size by Application
9.3.1 Asia Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024)
9.3.2 Asia Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030)
9.3.3 Asia Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
9.4 Asia Pancreatic Cancer Diagnostic Devices Market Size by Region
9.4.1 Asia Pancreatic Cancer Diagnostic Devices Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pancreatic Cancer Diagnostic Devices Market Size by Region (2019-2024)
9.4.3 Asia Pancreatic Cancer Diagnostic Devices Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Pancreatic Cancer Diagnostic Devices Introduction
11.1.4 Roche Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Pancreatic Cancer Diagnostic Devices Introduction
11.2.4 GE Healthcare Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.2.5 GE Healthcare Recent Developments
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Pancreatic Cancer Diagnostic Devices Introduction
11.3.4 Siemens Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.3.5 Siemens Recent Developments
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Pancreatic Cancer Diagnostic Devices Introduction
11.4.4 BD Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.4.5 BD Recent Developments
11.5 Philips Healthcare
11.5.1 Philips Healthcare Company Details
11.5.2 Philips Healthcare Business Overview
11.5.3 Philips Healthcare Pancreatic Cancer Diagnostic Devices Introduction
11.5.4 Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.5.5 Philips Healthcare Recent Developments
11.6 Hitachi Medical
11.6.1 Hitachi Medical Company Details
11.6.2 Hitachi Medical Business Overview
11.6.3 Hitachi Medical Pancreatic Cancer Diagnostic Devices Introduction
11.6.4 Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.6.5 Hitachi Medical Recent Developments
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Pancreatic Cancer Diagnostic Devices Introduction
11.7.4 Danaher Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.7.5 Danaher Recent Developments
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Pancreatic Cancer Diagnostic Devices Introduction
11.8.4 Abbott Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.8.5 Abbott Recent Developments
11.9 Canon Medical Systems
11.9.1 Canon Medical Systems Company Details
11.9.2 Canon Medical Systems Business Overview
11.9.3 Canon Medical Systems Pancreatic Cancer Diagnostic Devices Introduction
11.9.4 Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.9.5 Canon Medical Systems Recent Developments
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Pancreatic Cancer Diagnostic Devices Introduction
11.10.4 Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.10.5 Myriad Genetics Recent Developments
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Pancreatic Cancer Diagnostic Devices Introduction
11.11.4 Qiagen Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.11.5 Qiagen Recent Developments
11.12 Asuragen
11.12.1 Asuragen Company Details
11.12.2 Asuragen Business Overview
11.12.3 Asuragen Pancreatic Cancer Diagnostic Devices Introduction
11.12.4 Asuragen Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.12.5 Asuragen Recent Developments
11.13 BioMarker Strategies
11.13.1 BioMarker Strategies Company Details
11.13.2 BioMarker Strategies Business Overview
11.13.3 BioMarker Strategies Pancreatic Cancer Diagnostic Devices Introduction
11.13.4 BioMarker Strategies Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
11.13.5 BioMarker Strategies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Pancreatic Cancer Diagnostic Devices Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Imaging
    Table 3. Key Players of Tumor Biomarker
    Table 4. Key Players of Biopsy
    Table 5. Key Players of Others
    Table 6. Global Pancreatic Cancer Diagnostic Devices Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Pancreatic Cancer Diagnostic Devices Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Pancreatic Cancer Diagnostic Devices Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Pancreatic Cancer Diagnostic Devices Market Share by Region (2019-2024)
    Table 10. Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Pancreatic Cancer Diagnostic Devices Market Share by Region (2025-2030)
    Table 12. Pancreatic Cancer Diagnostic Devices Market Trends
    Table 13. Pancreatic Cancer Diagnostic Devices Market Drivers
    Table 14. Pancreatic Cancer Diagnostic Devices Market Challenges
    Table 15. Pancreatic Cancer Diagnostic Devices Market Restraints
    Table 16. Global Pancreatic Cancer Diagnostic Devices Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Pancreatic Cancer Diagnostic Devices Revenue Share by Players (2019-2024)
    Table 18. Global Top Pancreatic Cancer Diagnostic Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Cancer Diagnostic Devices as of 2023)
    Table 19. Global Pancreatic Cancer Diagnostic Devices Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Pancreatic Cancer Diagnostic Devices Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Pancreatic Cancer Diagnostic Devices, Headquarters and Area Served
    Table 22. Global Key Players of Pancreatic Cancer Diagnostic Devices, Product and Application
    Table 23. Global Key Players of Pancreatic Cancer Diagnostic Devices, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Type (2019-2024)
    Table 27. Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Pancreatic Cancer Diagnostic Devices Revenue Market Share by Type (2025-2030)
    Table 29. Global Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Pancreatic Cancer Diagnostic Devices Revenue Share by Application (2019-2024)
    Table 31. Global Pancreatic Cancer Diagnostic Devices Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Pancreatic Cancer Diagnostic Devices Revenue Share by Application (2025-2030)
    Table 33. North America Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Pancreatic Cancer Diagnostic Devices Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Pancreatic Cancer Diagnostic Devices Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Pancreatic Cancer Diagnostic Devices Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Pancreatic Cancer Diagnostic Devices Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Pancreatic Cancer Diagnostic Devices Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Pancreatic Cancer Diagnostic Devices Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Pancreatic Cancer Diagnostic Devices Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Pancreatic Cancer Diagnostic Devices Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Pancreatic Cancer Diagnostic Devices Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Roche Company Details
    Table 66. Roche Business Overview
    Table 67. Roche Pancreatic Cancer Diagnostic Devices Product
    Table 68. Roche Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 69. Roche Recent Developments
    Table 70. GE Healthcare Company Details
    Table 71. GE Healthcare Business Overview
    Table 72. GE Healthcare Pancreatic Cancer Diagnostic Devices Product
    Table 73. GE Healthcare Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 74. GE Healthcare Recent Developments
    Table 75. Siemens Company Details
    Table 76. Siemens Business Overview
    Table 77. Siemens Pancreatic Cancer Diagnostic Devices Product
    Table 78. Siemens Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 79. Siemens Recent Developments
    Table 80. BD Company Details
    Table 81. BD Business Overview
    Table 82. BD Pancreatic Cancer Diagnostic Devices Product
    Table 83. BD Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 84. BD Recent Developments
    Table 85. Philips Healthcare Company Details
    Table 86. Philips Healthcare Business Overview
    Table 87. Philips Healthcare Pancreatic Cancer Diagnostic Devices Product
    Table 88. Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 89. Philips Healthcare Recent Developments
    Table 90. Hitachi Medical Company Details
    Table 91. Hitachi Medical Business Overview
    Table 92. Hitachi Medical Pancreatic Cancer Diagnostic Devices Product
    Table 93. Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 94. Hitachi Medical Recent Developments
    Table 95. Danaher Company Details
    Table 96. Danaher Business Overview
    Table 97. Danaher Pancreatic Cancer Diagnostic Devices Product
    Table 98. Danaher Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 99. Danaher Recent Developments
    Table 100. Abbott Company Details
    Table 101. Abbott Business Overview
    Table 102. Abbott Pancreatic Cancer Diagnostic Devices Product
    Table 103. Abbott Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 104. Abbott Recent Developments
    Table 105. Canon Medical Systems Company Details
    Table 106. Canon Medical Systems Business Overview
    Table 107. Canon Medical Systems Pancreatic Cancer Diagnostic Devices Product
    Table 108. Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 109. Canon Medical Systems Recent Developments
    Table 110. Myriad Genetics Company Details
    Table 111. Myriad Genetics Business Overview
    Table 112. Myriad Genetics Pancreatic Cancer Diagnostic Devices Product
    Table 113. Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 114. Myriad Genetics Recent Developments
    Table 115. Qiagen Company Details
    Table 116. Qiagen Business Overview
    Table 117. Qiagen Pancreatic Cancer Diagnostic Devices Product
    Table 118. Qiagen Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 119. Qiagen Recent Developments
    Table 120. Asuragen Company Details
    Table 121. Asuragen Business Overview
    Table 122. Asuragen Pancreatic Cancer Diagnostic Devices Product
    Table 123. Asuragen Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 124. Asuragen Recent Developments
    Table 125. BioMarker Strategies Company Details
    Table 126. BioMarker Strategies Business Overview
    Table 127. BioMarker Strategies Pancreatic Cancer Diagnostic Devices Product
    Table 128. BioMarker Strategies Revenue in Pancreatic Cancer Diagnostic Devices Business (2019-2024) & (US$ Million)
    Table 129. BioMarker Strategies Recent Developments
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pancreatic Cancer Diagnostic Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Pancreatic Cancer Diagnostic Devices Market Share by Type: 2023 VS 2030
    Figure 3. Imaging Features
    Figure 4. Tumor Biomarker Features
    Figure 5. Biopsy Features
    Figure 6. Others Features
    Figure 7. Global Pancreatic Cancer Diagnostic Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Pancreatic Cancer Diagnostic Devices Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Others Case Studies
    Figure 12. Pancreatic Cancer Diagnostic Devices Report Years Considered
    Figure 13. Global Pancreatic Cancer Diagnostic Devices Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Pancreatic Cancer Diagnostic Devices Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Pancreatic Cancer Diagnostic Devices Market Share by Region: 2023 VS 2030
    Figure 16. Global Pancreatic Cancer Diagnostic Devices Market Share by Players in 2023
    Figure 17. Global Top Pancreatic Cancer Diagnostic Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Cancer Diagnostic Devices as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Pancreatic Cancer Diagnostic Devices Revenue in 2023
    Figure 19. North America Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
    Figure 21. North America Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
    Figure 22. North America Pancreatic Cancer Diagnostic Devices Market Share by Country (2019-2030)
    Figure 23. United States Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Pancreatic Cancer Diagnostic Devices Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
    Figure 27. Europe Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
    Figure 28. Europe Pancreatic Cancer Diagnostic Devices Market Share by Country (2019-2030)
    Figure 29. Germany Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Pancreatic Cancer Diagnostic Devices Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
    Figure 37. China Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
    Figure 38. Asia Pancreatic Cancer Diagnostic Devices Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
    Figure 40. Asia Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
    Figure 41. Asia Pancreatic Cancer Diagnostic Devices Market Share by Region (2019-2030)
    Figure 42. Japan Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Pancreatic Cancer Diagnostic Devices Market Share by Country (2019-2030)
    Figure 52. Brazil Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Pancreatic Cancer Diagnostic Devices Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Roche Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 59. GE Healthcare Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 60. Siemens Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 61. BD Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 62. Philips Healthcare Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 63. Hitachi Medical Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 64. Danaher Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 65. Abbott Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 66. Canon Medical Systems Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 67. Myriad Genetics Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 68. Qiagen Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 69. Asuragen Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 70. BioMarker Strategies Revenue Growth Rate in Pancreatic Cancer Diagnostic Devices Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS